Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Neriman Gokden

Concepts (361)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
13
2021
181
2.450
Why?
Carcinoma, Renal Cell
13
2021
112
2.130
Why?
Kidney Diseases
8
2020
230
1.080
Why?
Immunohistochemistry
14
2021
977
1.060
Why?
Kidney
16
2025
716
1.060
Why?
PAX2 Transcription Factor
4
2010
24
0.990
Why?
Kidney Tubules
7
2021
63
0.960
Why?
Acute Kidney Injury
9
2025
389
0.740
Why?
Immunoglobulin Light Chains
4
2017
90
0.740
Why?
Neoplasms, Complex and Mixed
1
2020
2
0.670
Why?
Rhabdoid Tumor
1
2020
13
0.660
Why?
Stromal Cells
1
2020
76
0.650
Why?
Soft Tissue Neoplasms
1
2020
56
0.630
Why?
Immune Complex Diseases
2
2008
6
0.550
Why?
Sepsis
7
2014
236
0.510
Why?
Mitogen-Activated Protein Kinases
2
2008
152
0.470
Why?
Adenoma
2
2021
114
0.420
Why?
Adenoma, Oxyphilic
2
2010
11
0.410
Why?
Male
39
2025
26874
0.400
Why?
Carcinoma, Papillary
2
2010
49
0.390
Why?
Renal Circulation
5
2013
56
0.360
Why?
Middle Aged
26
2025
13133
0.360
Why?
Prostatic Neoplasms
5
2010
398
0.360
Why?
Proteinuria
2
2010
40
0.340
Why?
Humans
44
2025
52441
0.340
Why?
Glomerulonephritis, IGA
1
2010
5
0.340
Why?
Podocytes
1
2010
21
0.330
Why?
Microcirculation
5
2014
64
0.330
Why?
Nephrectomy
2
2010
81
0.330
Why?
Antigens, Neoplasm
2
2008
145
0.320
Why?
Microscopy, Electron, Transmission
5
2014
68
0.320
Why?
Neurofibromatosis 2
1
2009
7
0.310
Why?
DNA Glycosylases
1
2008
19
0.290
Why?
Adult
19
2023
14205
0.280
Why?
Female
26
2025
28277
0.280
Why?
Renal Insufficiency
4
2013
109
0.280
Why?
Lymph Nodes
1
2010
253
0.280
Why?
Plasmacytoma
2
2020
44
0.280
Why?
Kidney Glomerulus
1
2008
41
0.280
Why?
Diagnosis, Differential
6
2021
1028
0.260
Why?
Hypercalcemia
1
2007
34
0.260
Why?
DNA Repair
1
2008
194
0.260
Why?
Alphapapillomavirus
1
2006
13
0.260
Why?
Sensitivity and Specificity
5
2011
871
0.250
Why?
Predictive Value of Tests
6
2025
938
0.250
Why?
Carcinoma
2
2020
135
0.250
Why?
Bone Density Conservation Agents
1
2007
75
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
62
0.250
Why?
Glomerulosclerosis, Focal Segmental
1
2006
17
0.250
Why?
Imidazoles
1
2007
114
0.250
Why?
Diphosphonates
1
2007
92
0.250
Why?
Hepatitis B
1
2006
15
0.250
Why?
DNA, Viral
1
2006
134
0.250
Why?
Urinary Bladder Neoplasms
3
2014
166
0.250
Why?
Prostatic Intraepithelial Neoplasia
2
2005
8
0.240
Why?
Complement C5
1
2025
4
0.240
Why?
Biopsy
6
2020
594
0.240
Why?
Skin Neoplasms
2
2018
496
0.230
Why?
Adenocarcinoma
2
2010
403
0.230
Why?
Cisplatin
4
2025
282
0.230
Why?
Insulin-Like Growth Factor Binding Protein 1
1
2025
16
0.230
Why?
Reperfusion Injury
1
2025
73
0.230
Why?
Neoplasms, Multiple Primary
1
2005
44
0.220
Why?
Aged
14
2025
10242
0.220
Why?
Metformin
1
2025
82
0.210
Why?
Paraproteinemias
2
2016
72
0.210
Why?
Pheochromocytoma
1
2023
35
0.200
Why?
Adrenal Gland Neoplasms
1
2023
49
0.200
Why?
Aged, 80 and over
8
2017
3449
0.200
Why?
Hypoglycemic Agents
1
2025
223
0.200
Why?
Dermatofibrosarcoma
1
2003
9
0.200
Why?
Proteasome Endopeptidase Complex
1
2024
137
0.200
Why?
Oncogene Proteins, Fusion
1
2003
61
0.190
Why?
Renal Insufficiency, Chronic
1
2025
198
0.190
Why?
Kidney Transplantation
1
2024
199
0.180
Why?
Animals
17
2025
13485
0.180
Why?
Kidney Diseases, Cystic
1
2021
18
0.170
Why?
Multiple Myeloma
3
2017
3013
0.170
Why?
Immunoglobulin G
2
2014
193
0.170
Why?
Disease Models, Animal
6
2025
1483
0.170
Why?
Precancerous Conditions
1
2021
87
0.170
Why?
Carcinoma, Transitional Cell
2
2012
54
0.160
Why?
Qb-SNARE Proteins
1
2019
6
0.160
Why?
Qc-SNARE Proteins
1
2019
10
0.160
Why?
Actin Cytoskeleton
1
2019
22
0.160
Why?
Neoplasms, Plasma Cell
1
2020
35
0.160
Why?
Hepatic Stellate Cells
1
2019
18
0.160
Why?
Antineoplastic Agents
3
2017
1216
0.160
Why?
Myofibroblasts
1
2019
50
0.150
Why?
Retrospective Studies
6
2025
6694
0.150
Why?
Kidney Failure, Chronic
1
2021
205
0.150
Why?
Neoplasm Metastasis
2
2010
235
0.150
Why?
Cell Nucleus
2
2010
189
0.150
Why?
Mice
12
2025
5899
0.150
Why?
Myoblasts
1
2018
19
0.140
Why?
Melanoma
2
2018
272
0.140
Why?
Synovitis
1
2017
20
0.130
Why?
Eosinophilia
1
2017
32
0.130
Why?
Cell Proliferation
1
2021
1013
0.130
Why?
Capillaries
4
2014
53
0.130
Why?
Obesity
1
2025
1176
0.130
Why?
DNA, Neoplasm
3
2008
146
0.130
Why?
Angiomyolipoma
1
2016
9
0.120
Why?
Rats
4
2025
3228
0.120
Why?
Thoracic Neoplasms
1
2016
13
0.120
Why?
Tuberous Sclerosis
1
2016
37
0.120
Why?
Tumor Suppressor Proteins
1
2016
127
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2017
230
0.120
Why?
Receptors, Lysosphingolipid
1
2014
6
0.110
Why?
Reactive Nitrogen Species
3
2011
23
0.110
Why?
Urothelium
1
2014
19
0.110
Why?
Hemangiosarcoma
1
2014
18
0.110
Why?
Mice, Inbred C57BL
6
2025
1888
0.110
Why?
Neoplasm Staging
3
2014
768
0.110
Why?
Oxidative Stress
2
2025
805
0.110
Why?
Immunoglobulin kappa-Chains
1
2014
22
0.110
Why?
Necrosis
2
2012
169
0.100
Why?
Glomerulonephritis, Membranous
1
2014
28
0.100
Why?
Rolipram
1
2013
2
0.100
Why?
Phosphodiesterase 4 Inhibitors
1
2013
4
0.100
Why?
Microscopy, Electron
2
2020
62
0.100
Why?
Molecular Targeted Therapy
1
2014
135
0.100
Why?
Glomerular Filtration Rate
4
2017
126
0.100
Why?
Translocation, Genetic
2
2005
266
0.100
Why?
Sarcoidosis
1
2013
43
0.100
Why?
Organ Preservation
2
2024
33
0.100
Why?
Prospective Studies
2
2010
2433
0.100
Why?
Livedo Reticularis
1
2012
5
0.100
Why?
Cryoglobulinemia
1
2012
13
0.100
Why?
Lipoprotein Lipase
1
2012
14
0.090
Why?
DNA, Mitochondrial
2
2003
112
0.090
Why?
Metalloporphyrins
1
2011
6
0.090
Why?
Free Radical Scavengers
1
2011
24
0.090
Why?
Cellular Microenvironment
1
2011
29
0.090
Why?
Adrenal Cortex Neoplasms
1
2011
5
0.090
Why?
Microscopy, Fluorescence
2
2014
140
0.090
Why?
Polymerase Chain Reaction
3
2008
458
0.090
Why?
Triglycerides
1
2012
171
0.090
Why?
Myocardium
2
2017
471
0.090
Why?
Stilbenes
1
2011
58
0.090
Why?
Tissue Array Analysis
2
2011
45
0.090
Why?
Peritoneal Neoplasms
1
2012
66
0.080
Why?
Metalloendopeptidases
1
2011
70
0.080
Why?
Hematuria
1
2010
25
0.080
Why?
Fluorescent Antibody Technique
1
2010
110
0.080
Why?
Ejaculatory Ducts
1
2010
3
0.080
Why?
Seminal Vesicles
1
2010
13
0.080
Why?
Plasma Cells
1
2012
233
0.080
Why?
Hemodynamics
1
2011
235
0.080
Why?
Antioxidants
1
2011
255
0.080
Why?
RNA, Messenger
4
2012
1134
0.080
Why?
In Situ Hybridization
2
2006
69
0.080
Why?
Prostate
1
2010
116
0.080
Why?
Epithelial Cells
2
2011
217
0.080
Why?
Lymphatic Metastasis
1
2010
210
0.080
Why?
Fatal Outcome
1
2009
193
0.070
Why?
Survival Analysis
3
2017
656
0.070
Why?
Iron Chelating Agents
1
2008
12
0.070
Why?
Ligation
3
2014
62
0.070
Why?
Nephritis, Interstitial
1
2008
9
0.070
Why?
Benzoates
1
2008
22
0.070
Why?
Microsatellite Repeats
1
2008
42
0.070
Why?
Glomerular Mesangium
1
2008
7
0.070
Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
Why?
Loss of Heterozygosity
1
2008
78
0.070
Why?
Basement Membrane
1
2008
19
0.070
Why?
Triazoles
1
2008
115
0.070
Why?
Cell Membrane
1
2008
238
0.070
Why?
Disease Progression
2
2025
870
0.070
Why?
Glomerular Basement Membrane
1
2007
9
0.070
Why?
Mutation
2
2003
1331
0.070
Why?
Kidney Pelvis
1
2006
16
0.060
Why?
Prednisone
1
2007
100
0.060
Why?
Paraffin Embedding
1
2006
52
0.060
Why?
Tumor Necrosis Factor-alpha
2
2025
390
0.060
Why?
Karyotyping
3
2017
77
0.060
Why?
Rats, Sprague-Dawley
2
2025
1558
0.060
Why?
Heart Diseases
1
2009
217
0.060
Why?
Prognosis
2
2025
2100
0.060
Why?
Young Adult
4
2021
4346
0.060
Why?
Nephrotic Syndrome
1
2006
34
0.060
Why?
Gene Knockout Techniques
1
2025
50
0.060
Why?
Mice, Knockout
2
2025
903
0.060
Why?
Clofibric Acid
1
2005
7
0.060
Why?
Chromosomes, Human, Pair 2
1
2005
25
0.060
Why?
Chromosomes, Human, Pair 7
1
2005
29
0.060
Why?
Chemokine CCL2
1
2025
65
0.060
Why?
Rats, Zucker
1
2025
73
0.060
Why?
Lipopolysaccharides
1
2006
205
0.060
Why?
Glucocorticoids
1
2007
234
0.060
Why?
Chromosomes, Human, Pair 5
1
2005
17
0.060
Why?
Chromosomes, Human, Pair 9
1
2005
20
0.060
Why?
Neurofibroma
1
2005
17
0.060
Why?
Foot
1
2005
40
0.060
Why?
Anti-Bacterial Agents
1
2011
816
0.060
Why?
Fibroma
1
2005
40
0.060
Why?
Blood Pressure
3
2011
525
0.060
Why?
Protein Synthesis Inhibitors
1
2004
16
0.060
Why?
Biopsy, Needle
1
2005
181
0.050
Why?
Endodeoxyribonucleases
1
2004
47
0.050
Why?
Administration, Oral
1
2025
455
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
123
0.050
Why?
Adrenalectomy
1
2023
33
0.050
Why?
Adrenal Glands
1
2023
38
0.050
Why?
Gene Expression Regulation, Enzymologic
1
2004
180
0.050
Why?
Groin
1
2003
16
0.050
Why?
Vulva
1
2003
18
0.050
Why?
Proteasome Inhibitors
1
2024
101
0.050
Why?
RNA, Neoplasm
1
2003
45
0.050
Why?
Time Factors
3
2014
2987
0.050
Why?
Micromanipulation
1
2002
2
0.050
Why?
Cytoplasm
1
2003
93
0.050
Why?
Immunoenzyme Techniques
1
2003
134
0.050
Why?
Biopsy, Fine-Needle
1
2003
104
0.050
Why?
Blotting, Western
3
2012
587
0.050
Why?
Perfusion
1
2002
49
0.050
Why?
Sodium Chloride
1
2002
55
0.050
Why?
Neoplasm Invasiveness
2
2014
278
0.050
Why?
Blood Flow Velocity
2
2013
97
0.050
Why?
Sequence Analysis, DNA
1
2003
220
0.050
Why?
Hypothermia, Induced
1
2002
46
0.050
Why?
Mass Screening
1
2005
354
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
580
0.050
Why?
Capillary Permeability
2
2011
29
0.040
Why?
Cardiac Surgical Procedures
1
2025
329
0.040
Why?
Severity of Illness Index
1
2025
1045
0.040
Why?
Adolescent
3
2014
6713
0.040
Why?
Bone Neoplasms
1
2003
188
0.040
Why?
Hyperplasia
1
2021
96
0.040
Why?
Inflammation
1
2025
649
0.040
Why?
Transcription Factors
1
2004
570
0.040
Why?
Liver
2
2019
1150
0.040
Why?
Cell Differentiation
2
2014
667
0.040
Why?
Clinical Laboratory Techniques
1
2020
28
0.040
Why?
Apoptosis
1
2025
1120
0.040
Why?
In Situ Hybridization, Fluorescence
1
2021
262
0.040
Why?
Heart Rate
2
2011
311
0.040
Why?
Stress Fibers
1
2019
5
0.040
Why?
Actin Depolymerizing Factors
1
2019
5
0.040
Why?
rho-Associated Kinases
1
2019
18
0.040
Why?
Treatment Outcome
3
2017
5508
0.040
Why?
Carbon Tetrachloride
1
2019
25
0.040
Why?
RNA, Viral
1
2020
123
0.040
Why?
Cell Separation
1
2019
78
0.040
Why?
Gene Knockdown Techniques
1
2019
110
0.040
Why?
Nitrites
2
2011
32
0.040
Why?
Liver Neoplasms
1
2003
341
0.040
Why?
Child, Preschool
2
2011
4046
0.040
Why?
Nitrates
2
2011
31
0.040
Why?
Antibodies, Monoclonal
1
2003
475
0.040
Why?
Actins
1
2019
112
0.040
Why?
Cecum
2
2011
56
0.040
Why?
Neutrophil Infiltration
2
2012
26
0.040
Why?
RNA Interference
1
2019
183
0.040
Why?
RNA, Small Interfering
1
2019
217
0.040
Why?
Cell Movement
1
2019
271
0.040
Why?
Cell Dedifferentiation
1
2018
8
0.040
Why?
Wound Healing
1
2019
223
0.030
Why?
Reactive Oxygen Species
2
2011
415
0.030
Why?
Kidney Function Tests
1
2017
56
0.030
Why?
Liver Cirrhosis
1
2019
243
0.030
Why?
Microscopy, Video
2
2007
8
0.030
Why?
Cell Line
1
2019
1020
0.030
Why?
Nitric Oxide Synthase Type II
2
2007
62
0.030
Why?
Lung Neoplasms
1
2003
643
0.030
Why?
Acute Disease
2
2008
384
0.030
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.030
Why?
Risk Factors
1
2005
3971
0.030
Why?
Genomics
1
2017
266
0.030
Why?
Cysts
1
2016
48
0.030
Why?
Bone Marrow
1
2017
354
0.030
Why?
Immunotherapy
1
2017
251
0.030
Why?
Oxadiazoles
1
2014
9
0.030
Why?
Punctures
1
2014
50
0.030
Why?
Permeability
1
2014
69
0.030
Why?
Thiophenes
1
2014
45
0.030
Why?
Antigen-Antibody Complex
1
2014
35
0.030
Why?
Terminology as Topic
1
2014
69
0.030
Why?
Pyrazoles
1
2014
116
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
73
0.030
Why?
Pyridines
1
2014
137
0.030
Why?
Granuloma
1
2013
45
0.030
Why?
Signal Transduction
1
2019
1724
0.020
Why?
Bone Marrow Examination
1
2012
11
0.020
Why?
Receptors, Lipoprotein
1
2012
7
0.020
Why?
Azo Compounds
1
2012
11
0.020
Why?
Angiopoietins
1
2012
6
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2012
16
0.020
Why?
Plasma Exchange
1
2012
25
0.020
Why?
Coloring Agents
1
2012
68
0.020
Why?
Adipose Tissue, White
1
2012
34
0.020
Why?
Immunosuppressive Agents
1
2014
248
0.020
Why?
Epithelium
1
2011
65
0.020
Why?
Cystectomy
1
2012
52
0.020
Why?
Cell Hypoxia
1
2011
82
0.020
Why?
Superoxide Dismutase
1
2011
120
0.020
Why?
Child
2
2016
7194
0.020
Why?
Telemetry
1
2011
27
0.020
Why?
Dose-Response Relationship, Drug
1
2014
1365
0.020
Why?
Peritonitis
1
2011
24
0.020
Why?
Vasodilator Agents
1
2011
90
0.020
Why?
Multiple Organ Failure
1
2011
48
0.020
Why?
Hydroxamic Acids
1
2011
38
0.020
Why?
Hypothermia
1
2011
38
0.020
Why?
Fluid Therapy
1
2011
80
0.020
Why?
Oxidation-Reduction
1
2011
327
0.020
Why?
United States
1
2021
5215
0.020
Why?
Interleukin-1beta
1
2011
84
0.020
Why?
Animals, Newborn
1
2011
355
0.020
Why?
Body Weight
1
2012
524
0.020
Why?
Membrane Proteins
1
2012
344
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Skin
1
2012
416
0.020
Why?
Infant, Newborn
1
2016
2871
0.020
Why?
Iron Overload
1
2008
9
0.020
Why?
Cells, Cultured
1
2012
1583
0.020
Why?
Eosinophils
1
2008
39
0.020
Why?
Erythrocyte Transfusion
1
2008
52
0.020
Why?
Drug Hypersensitivity
1
2008
42
0.020
Why?
Myelodysplastic Syndromes
1
2008
86
0.020
Why?
NADP
1
2006
22
0.020
Why?
Blood Urea Nitrogen
1
2006
40
0.020
Why?
Lysine
1
2007
90
0.020
Why?
Creatinine
1
2006
156
0.020
Why?
Nitric Oxide
1
2007
238
0.010
Why?
Nuclease Protection Assays
1
2005
2
0.010
Why?
Receptors, CCR1
1
2005
10
0.010
Why?
Receptors, CCR5
1
2005
7
0.010
Why?
Receptors, Chemokine
1
2005
13
0.010
Why?
Chemokine CCL5
1
2005
9
0.010
Why?
Stress, Physiological
1
2006
183
0.010
Why?
Electrophoretic Mobility Shift Assay
1
2005
71
0.010
Why?
Intercellular Adhesion Molecule-1
1
2005
59
0.010
Why?
Vascular Cell Adhesion Molecule-1
1
2005
38
0.010
Why?
Enzyme Inhibitors
1
2007
378
0.010
Why?
Muscle Neoplasms
1
2005
16
0.010
Why?
Chemokines
1
2005
77
0.010
Why?
PPAR alpha
1
2005
61
0.010
Why?
Prostatectomy
1
2005
84
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2005
234
0.010
Why?
Chromosome Mapping
1
2005
149
0.010
Why?
Kidney Tubules, Proximal
1
2004
60
0.010
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
67
0.010
Why?
Ligands
1
2004
205
0.010
Why?
Cell Death
1
2004
169
0.010
Why?
Antigens, CD
1
2005
213
0.010
Why?
Pyrimidines
1
2005
199
0.010
Why?
NF-kappa B
1
2005
326
0.010
Why?
Models, Genetic
1
2003
173
0.010
Why?
Multigene Family
1
2002
49
0.010
Why?
Lasers
1
2002
64
0.010
Why?
Infant
1
2011
3709
0.010
Why?
Renal Artery Obstruction
1
2002
20
0.010
Why?
Base Sequence
1
2003
632
0.010
Why?
Cytokines
1
2005
622
0.010
Why?
Polymorphism, Genetic
1
2002
184
0.010
Why?
Models, Animal
1
2002
230
0.010
Why?
Ischemia
1
2002
150
0.010
Why?
Swine
1
2002
428
0.010
Why?
Feasibility Studies
1
2002
404
0.010
Why?
Laparoscopy
1
2002
180
0.010
Why?
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description